Torrance, March 30, 2016: Phenomenex Inc., a global leader in the research, design and manufacture of advanced technologies for the separation sciences, introduces Luna Omega 1.6µm columns, an expansion of its flagshipliquid chromatography line for UHPLC applications. Luna is one of the most recognized HPLC brands on the market, delivering high efficiency, ruggedness, reproducibility and dependability for a wide range of analyses since its launchin 1996. The new Luna Omega 1.6µm builds upon this legacy with an innovativeUHPLC silica particle architecture,designed and manufactured by Phenomenex based onmore than 20 years of applied knowledge, invention and customer experience. The new 1.6µmUHPLC columns deliverimproved performance compared to other sub-2µm products on the market, along withexceptionally tight particle size distribution, high column packing efficiencies, steady selectivity and excellent reproducibility.Luna Omega columns are well suited for a wide range of applications including drug discovery and development, food contaminant analysis, environmental testing, toxicology and clinical research.
“Our Luna HPLCbrand has been a proven staple in laboratories worldwide for the past 20 years, thanks to itsestablishedreliability and high quality,” commented Simon Lomas, strategic marketing manager for Phenomenex. “We are excited to now bring these attributes and technology to UHPLC applications, and to expand upon it with highly versatile and unique selectivities in the near future.”
Luna Omega UHPLC columns feature a novel silicawith a constant particle morphology that is modified with proprietary, post-synthetic thermal treatment processes for mechanical strength and inertness. This provides significantly better peak shape for compounds of interest and minimizes unwanted secondary interactions.ProprietaryPhenomenex bonding technologiesensure wide stationary phase coverage and excellent separation power.
Kinetex® Core-Shell Technology and Luna Omega columns together provide an ideal complementary UHPLC solution for greater efficiency and separation power. With a growing range of valuable selectivities, this pairing of core-shell and fully porous UHPLC products affords customers a better choice for immediate gains in productivity, resolution and retention. Combinations such as such as Luna Omega 1.6µm C18 with Kinetex 1.7µm Biphenyl and Kinetex 1.7µm F5 promote greater method development success.
Phenomenex is a global technology leader committed to developing novel analytical chemistry solutions that solve the separation and purification challenges of researchers in industrial, clinical research, government and academic laboratories. From drug discovery and pharmaceutical development to food safety and environmental analysis, Phenomenex chromatography solutions accelerate science and help researchers improve global health and well-being. For more information on Phenomenex, visit www.phenomenex.com or follow the company on Twitter @Phenomenex.
Corporate Comm India (CCI Newswire)
By Dr. Priyanka Kuri, Consultant - Dermatology, Aster Whitefield Hospital, Bengaluru Insomnia, the persistent inability…
Illuminating Latest Advances in Migraine Diagnosis and Treatment New Delhi, December 21, 2024: In a…
New Delhi, December 20, 2024: The healthcare sector is undergoing a transformation fueled by technological…
National, December 20, 2024: DKMS just published its first Global Impact Report that outlines the organization's…
Ahmedabad, December 19, 2024: Sterling Biotech Limited, a joint venture between Perfect Day and Zydus, has…
New Delhi, December 19, 2024: Antara Senior Care, an integrated eco-system provider for lifestyle and…